Saibia Immunofixation Electrophoresis Daratumumab Test Kit
Taiwan·Risk Class 2·SEBIA·Registered Jun 24, 2021 – Jun 24, 2026Expired- Analysis ID
- 275f8a96690f31571dfabe2896924cec
- Customs Code
- DHA05603466708
- Manufacturer
- SEBIA
- Manufacturer Country
- France
- Authorized Representative
- ARQon Medtech Co., Ltd.
- Intended Use
- This product is paired with HYDRAGEL IF detection reagent and semi-automated HYDRASYS 2 electrophoresis equipment, HYDRAGEL IF detects monoclonal antibodies in human serum by immunofixation electrophoresis.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jun 24, 2021
- Expiry Date
- Jun 24, 2026
Top companies providing products similar to "Saibia Immunofixation Electrophoresis Daratumumab Test Kit"
Recently registered similar products
Access comprehensive regulatory information for Saibia Immunofixation Electrophoresis Daratumumab Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 275f8a96690f31571dfabe2896924cec and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including SEBIA, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.